VBI Assistant Professor Iuliana Lazar.
The technique has allowed the scientists to look at how the degrees of proteins change in breast cancers cells when they are treated with hormones or cancer medicines like tamoxifen. VBI Assistant Professor Iuliana Lazar, along with VBI Professor Ina VBI and Hoeschele Postdoctoral Associate Jenny Armenta, developed the technique*, which uses proteomic technology for fast biomarker fingerprinting in complex cellular extracts. The purpose of biomarker discovery and screening is usually to recognize changes in the degrees of crucial proteins in the cell in response to the onset or advancement of a disease. The scientific community has invested extensive efforts in to the development of strategies that would enable the sensitive screening of large panels of biomarkers, instead of just one at a time.In low – and middle-income countries, drug resistance stood at 6.8 % in 2010 2010, the WHO stated in its first-ever report on the matter, the news headlines agency writes, adding, High-income countries, a lot of which began widescale treatment for HIV years earlier and used single or dual therapies that can also encourage resistance, face higher rates of resistance, from eight to 14 %, said the analysis . Related StoriesRutgers College of Nursing takes lead in $6 million nationwide effort to prevent brand-new HIV infectionsNew initiative released to accelerate search for effective HIV vaccinePitt Public Health launches study to promote health among aging gay and bisexual males with HIVAccording to a WHO news release, Some degree of HIV drug resistance is normally expected to occur due to organic mutations in the virus; but most instances of drug level of resistance are caused by preventable factors such as for example treatment interruptions and individuals taking medicines incorrectly.